Why the study?
Does cardiac revascularization improve the Myocardial Performance Index (Tei index) in patients with chronic ischemic cardiomyopathy and viable myocardium?
Does cardiac revascularization improve the Myocardial Performance Index (Tei index) in patients with chronic ischemic cardiomyopathy and viable myocardium?
In patients with chronic ischemic cardiomyopathy, the Myocardial Performance Index (Tei index) improves following revascularization, closely reflecting the recovery of left ventricular function.
Answers are grounded in this paper and cite their sources.
MPI improvement post-revascularization may mark LV recovery in ischemic cardiomyopathy; leaves open its utility for viability assessment or outcome prediction.
BACKGROUND: Myocardial performance index (MPI), or Tei index, is an indicator of systolic and diastolic myocardial function. MPI increases in case of cardiac dysfunction; however, whether reversal of left ventricular dysfunction is also reflected by concomitant improvement (i.e., decrease) of MPI is unknown. METHODS: Fifty-two patients with chronic ischemic cardiomyopathy and viable myocardium by dobutamine stress echocardiography were studied by echocardiography before and more than 4 months after cardiac revascularization. Patients were in optimal medical therapy, which remained unchanged following revascularization. RESULTS: At baseline, ejection fraction (EF: 32 ± 6%) and wall motion score index (WMSI: 2.37 ± 0.32) were impaired, and MPI averaged 0.71 ± 0.19. Revascularization markedly improved EF (44 ± 10%, P < 0.0001) and WMSI (1.77 ± 0.44, P < 0.0001). MPI also improved (0.59 ± 0.26, P < 0.0001), and its decrease was significantly correlated with the improvement in EF (r =-0.68, P < 0.0001) and to the extent of viable myocardium (r =-0.45, P = 0.0007). Responders to revascularization (≥5% increase in EF at follow-up, n = 40% and 77%) achieved a significant improvement in MPI at follow-up in contrast with nonresponders (-23 ± 25% vs. 0.02 ± 0.18%, P = 0.001). Improvement in MPI was largely driven by a significant reduction in isovolumic contraction time (P < 0.001) with consequent prolongation of the ejection phase. CONCLUSION: In patients with chronic ischemic cardiomyopathy, MPI improves along with recovery of function, reflecting the intrinsic improvement of viable segments induced by revascularization.
No takes yet. Share an insight, caveat, or question.
Carluccio et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: